Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands
Open Access
- 1 March 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 121 (1), 127-135
- https://doi.org/10.1002/ijc.22625
Abstract
The relatively small group of patients with breast tumors other than the ductal, lobular or mixed ducto-lobular types, has reached nonnegligible numbers due to the ongoing increase in the incidence of breast cancer. We investigated stage and grade distribution of uncommon breast tumors using the nation-wide Netherlands Cancer Registry (population 16.5 million) and incidence patterns, treatment and long-term survival (up to 19 years) using the regional Eindhoven Cancer Registry (population 2.4 million). Incidence of all uncommon breast tumors together was 9.2/100,000 person years (age-standardized, ESR). The proportion of stage I tumors was 70% among patients with tubular (n = 3,456) and 40–50% for mucinous (n = 3,482), papillary (n = 1,078), cribriform (n = 503) and neuroendocrine (n = 76) tumors, contrasting to 27, 28 and 36%, respectively among patients with Signet ring cell cancer (n = 75), Paget's disease (n = 818) and the common invasive ductal carcinomas (n = 121,656). A better age-, stage-, and grade-adjusted prognosis was observed for patients with lobular (death risk ratio 0.8, 95%CI: 0.7–0.9), mucinous (0.5, 0.3–0.9), medullary (0.5, 0.3–0.9) and tubular (0.4, 0.2–0.6) carcinoma or phyllodes tumor (0.02, 0.0–0.2), compared with invasive ductal carcinomas. For patients with papillary (0.6, 0.2–1.6) and cribriform (0.1, 0.0–5.1) tumors better prognosis was not statistically significant. In conclusion, histologic type was an essential determinant of survival for about 10% of all newly diagnosed women with invasive breast cancer. Because patients with mucinous, tubular, medullary and phyllodes tumors have such a good prognosis, less aggressive treatment should be considered in some cases whereby specific guidelines are becoming increasingly desirable. Communication to patients with these specific histological types should reflect this.This publication has 41 references indexed in Scilit:
- Tubular CarcinomaPublished by Wiley ,2006
- Phyllodes Tumor of the BreastPublished by Wiley ,2006
- Adenoid Cystic Carcinoma of the BreastPublished by Wiley ,2006
- Metaplastic Breast CarcinomaPublished by Wiley ,2006
- Tubular Carcinoma of the Breast: a Retrospective Analysis and Review of the LiteratureBreast Cancer Research and Treatment, 2005
- Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: A population-based studyEuropean Journal of Cancer, 2005
- Regression models for relative survivalStatistics in Medicine, 2003
- The importance of histologic type on breast cancer survivalJournal of Clinical Epidemiology, 1997
- Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancerEuropean Journal of Cancer, 1995
- A computer program package for relative survival analysisComputer Programs in Biomedicine, 1985